2019Â -Â Present | Clinical Professor, Department of Interventional Radiology, Florida International University ‐ Herbert Wertheim College of Medicine | |
|
||
2018Â -Â Present | Affiliate Associate Clinical Professor, University of South Florida ‐ College of Medicine | |
|
||
2017Â -Â Present | Attending Radiologist, Baptist Health South Florida ‐ Miami Cancer Institute | |
|
||
2011Â -Â Present | Attending Radiologist, Baptist Health South Florida ‐ West Kendall Baptist Hospital | |
|
||
2009Â -Â Present | Attending Radiologist, Baptist Health South Florida ‐ South Miami Hospital | |
|
||
2009Â -Â Present | Attending Radiologist, Baptist Health South Florida ‐ Homestead Hospital | |
|
||
2009Â -Â Present | Attending Radiologist, Baptist Health South Florida ‐ Doctors Hospital | |
|
||
2009Â -Â Present | Interventional Radiologist, Miami Vascular Specialists | |
|
||
2009Â -Â Present | Vascular & Interventional Radiologist/Vascular Medicine, Baptist Health South Florida ‐ Miami Cardiac & Vascular Institute | |
|
||
2010Â -Â 2019 | Associate Clinical Professor, Department of Interventional Radiology, Florida International University ‐ Herbert Wertheim College of Medicine | |
|
||
2009Â -Â 2018 | Affiliate Assistant Professor, University of South Florida ‐ College of Medicine | |
|
||
2009Â -Â 2011 | Voluntary Assistant Professor of Radiology, University of California Los Angeles ‐ David Geffen School of Medicine | |
|
||
2007Â -Â 2009 | International Visiting Scholar, Interventional Radiology, Asan Medical Center | |
|
||
2002Â -Â 2003 | Research Fellow, Memorial Sloan-Kettering Cancer Center | |
|
||
1997Â -Â 2001 | Research Fellow, Northwestern University Medical School | |
|
||
1996Â -Â 1996 | Research Fellow, National Institutes of Health (NIH) ‐ Neuroscience Branch of National Institute on Drug Abuse | |
|
Disciplines
Research Interests
Grants
2020Â -Â Present | A Phase III Randomized, Double-Blind, Placebo Controlled, Multi-centre Study of Durvalumab Monotherapy or in Combination with Bevacizumab as Adjuvant Therapy in Patients with Hepatocellular Carcinoma who are at High Risk of Recurrence after Curative Hepatic Resection or Ablation (EMERALD-2). |
AstraZeneca - NCT03847428 | |
Role: Sub-Investigator | |
2020Â -Â Present | Liver Venous Deprivation and Transarterial Radioembolization in Preparation for Hepatectomy. |
Baptist Health South Florida | |
Role: Principal Investigator | |
2020Â -Â 2028 | Prospective, Multicenter, Non-randomized Study for the Evaluation of the ChEVAS System for Endovascular Repair of Paravisceral, Juxtarenal, and Pararenal Abdominal Aortic Aneurysms. |
Endologix - NCT04252573 | |
Role: Sub-Investigator | |
2018Â -Â 2027 | The DES BTK Vascular Stent System vs PTA in Patients with Critical Limb Ischemia (SAVAL). |
Boston Scientific Corporation - NCT03551496 | |
Role: Sub-Investigator | |
2021Â -Â 2026 | The HistoSonics System for Treatment of Primary and Metastatic Liver Tumors Using Histotripsy (#HOPE4LIVER US). |
HistoSonics, Inc. - NCT04572633 | |
Role: Sub-Investigator | |
2017Â -Â 2025 | Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix System IDE Study (EVAS 2 Confirmatory IDE Study). |
Endologix - NCT03298477 | |
Role: Sub-Investigator | |
2020Â -Â 2024 | Randomized Phase II Study of Radiation Therapy Alone Versus Radiation Therapy Plus Radiofrequency Ablation (RFA)/Vertebral Augmentation for Localized Spine Metastasis. |
Baptist Health South Florida, Medtronic - NCT04375891 | |
Role: Sub-Investigator | |
2019Â -Â 2023 | A Study of Patients with Lower Extremity Acute Limb Ischemia to Remove Thrombus with the Indigo Aspiration System (STRIDE). |
Penumbra Inc. - NCT04144959 | |
Role: Sub-Investigator | |
2018Â -Â 2023 | Targeted Intra-arterial Gemcitabine vs. Continuation of IV Gemcitabine plus Nab-Paclitaxel following Induction with sequential IV Gemcitabine plus Nab-Paclitaxel and Radiotherapy for Locally Advanced Pancreatic Cancer (TIGeR-PaC). |
RenovoRx - NCT03257033 | |
Role: Principal Investigator | |
2017Â -Â 2023 | The Detour Endovascular Technique for Long Occlusive Fem-pop Revascularization 2 Clinical Trial (The DETOUR 2 Clinical Trial). |
PQ Bypass, Inc. - NCT03119233 | |
Role: Sub-Investigator | |
2022Â -Â 2022 | A Prospective, Multi-Center, Single-Arm, Real World Study Assessing the Clinical Use of the Caterpillarâ„¢ Arterial Embolization Device for the Arterial Embolization in the Peripheral Vasculature. Caterpillar Arterial Embolization Device Post-Market Study (MONARCH). |
C. R. Bard - NCT04244370 | |
Role: Principal Investigator | |
2022Â -Â 2022 | Recombinant tPA by Endovascular Administration for the Treatment of Submassive Pulmonary Embolism using Pharmaco-Mechanical Catheter Directed Thrombolysis for the Reduction of Thrombus Burden (RESCUE study). |
Thrombolex, Inc., National Heart, Lung, and Blood Institute (NHLBI) - NCT04248868 | |
Role: Principal Investigator | |
2015 - 2022 | A Randomized Trial Comparing the ELUVIA™ Drug-eluting Stent Versus Zilver® PTX® Stent for Treatment of Superficial Femoral and/or Proximal Popliteal Arteries. |
Boston Scientific Corporation - NCT02574481; | |
Role: Sub-Investigator | |
2015Â -Â 2022 | Radiation-Emitting SIR-Spheres in Non-resectable (RESIN) Liver Tumor Patient Study. |
Vanderbilt-Ingram Cancer Center, National Cancer Institute (NCI) - NCT02685631 | |
Role: Principal Investigator | |
2014Â -Â 2022 | REHEARSAAAL Study Evaluating Simbionix Procedure Rehearsal Studio for the Treatment of Abdominal Aortic Aneurysms for EVAR. |
HealthCore - NERI - NCT02060630 | |
Role: Sub-Investigator | |
2017Â -Â 2021 | Efficacy, Tolerability and Safety of Intramuscular Injections of PLX-PAD for the Treatment of Subjects with Critical Limb Ischemia (CLI) with Minor Tissue Loss who are Unsuitable for Revascularization (PACE Study). |
Pluristem Ltd. - NCT03006770 | |
Role: Sub-Investigator | |
2018Â -Â 2020 | Accuracy of Simple Visual Estimation in Assessment of Hepatic Volumes and Tumor Infiltration in Dose Calculation for Yttrium-90 Radioembolization. |
Baptist Health South Florida - n/a | |
Role: Principal Investigator | |
2018Â -Â 2020 | Assessment of the GORE Excluder Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms. |
W.L. Gore & Associates - NCT02489539 | |
Role: Principal Investigator | |
2017Â -Â 2019 | A Clinical Study to Survey the Experience and Acceptability by Physicians using BTG-13-002 (LC Bead LUMI) for Embolization Procedures. |
BTG - n/a | |
Role: Principal Investigator | |
2017Â -Â 2019 | The Flex Arm Study Evaluating Flex Arm and C-arm Movement During Complex Structural Heart and Endovascular Procedures. |
Baptist Health South Florida - n/a | |
Role: Sub-Investigator |
Professional Service and Affiliations
Member, American Association of Physicians of Indian Origin | Member, American Association of Physicists in Medicine | Member, American College of Radiology | Member, American Medical Association | Member, Association of University Radiologists | Member, European Society of Radiology | Member, Florida Radiological Society | Student Advisor, Honors Program in Medical Education | Member, Indian Medical Society of Southern California | Member, International Society of Endovascular Specialists | Member, International Society of Extremity MRI in Rheumatology | Member, Los Angeles Radiological Society | Member, Miami Cancer Club | Founder, Northwestern University Loyal Davis Surgical Society | Member, Pulmonary Embolism Response Team (PERT) Consortium | Member, Radiological Society of North America | Member, Radiology Associates of South Florida | Member, Scientific and Professional Society Memberships | Fellow, Society for Vascular Medicine | Member, Society of Cardiovascular Computed Tomography |
Honors and Awards
- America’s Most Honored Doctors (2020, 2021)
- Florida’s Top Docs (2020, 2021)
- Compassionate Doctor Award (2020)
- On-Time Doctor Award (2020)
- Top Doctor (2017, 2020)
- Leading Physicians of the World (2017, 2018)
- America’s Best Physicians – by National Consumer Advisory Board (2016-2021)
- Worldwide Leader in Healthcare – by International Association of HealthCare Professionals (2016)
- IBC Top 100 Health Professionals Distinction Award (2015)
- Physician of the Quarter Performance Achievement Award - Baptist Cardiac & Vascular Institute (July-September 2012)
- Physician of Month Award - Baptist Cardiac and Vascular Institute (2011)
- Society of Interventional Radiology Leadership Development Academy (2011)
- Patients’ Choice Award for America's Most Compassionate Doctors (2009)
- International Visiting Scholar – Asan Medical Center in Seoul, Korea (2009)
- Patients’ Choice Recognition Award (2008-2011, 2020)
- American College of Physicians Award for Best Performance in Medicine
- Alpha Omega Alpha (AOA) Honor Society
- Phi Beta Kappa Honor Society
- Golden Key National Honor Society
- Alpha Lambda Delta Scholastic Honor Society
- Edward J. Bloustein Scholarship
- Robert C. Byrd Scholarship
- Federal Employee Education & Assistance Fund (FEEA) Scholarship
- Medical Student Research Scholarship
- National Institutes of Health (NIH) Research Scholarship
2008Â -Â 2009 | Clinical Instructor in Interventional Radiology, Fellow, University of California Los Angeles ‐ Medical Center | |
|
||
2007Â -Â 2008 | MRI/Musculoskeletal and Spine Imaging, Fellow, RadNet Imaging | |
|
||
2003Â -Â 2007 | Diagnostic Radiology, Resident, University of California Los Angeles ‐ Medical Center | |
|
||
2002Â -Â 2003 | Research Fellow in Vascular and Interventional Radiology, Memorial Sloan-Kettering Cancer Center | |
|
||
2001Â -Â 2002 | Surgical Intern, Cornell University Medical Center ‐ New York Presbyterian Hospital | |
|
||
1997Â -Â 2001 | Doctor of Medicine, Northwestern University ‐ Feinberg School of Medicine | |
|
||
1994Â -Â 1997 | Bachelor of Science, Biology, Northwestern University | |
|
||
1993Â -Â 1993 | General and Inorganic Chemistry, Harvard University | |
|
Contact Information
8900 North Kendall Drive
Miami, FL 33176
(786) 596-7050